Is the halt related to the following on Page 2
https://botanixpharma.com/wp-content/uploads/BOT.ASX-BOT-Successful-FDA-MidCycle-Review-040623.pdf
BOT had $8.7m in cash as of the december quarter. BOT is not due to make the nextUS$4m milestone payment to Fresh Tracks Therapeutics (previously Brickell Biotech) untilthe receipt of FDA approval (if received before 30th September, less due if thereafter).
Other milestone payments due to Fresh Tracks are tied to net sales, and won’t begin untilnet sales exceed US$75m per annum.
Ann: Trading Halt, page-66
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.005M | 2.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 312537 | 10 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |